As Dr. Patterson said in his TedTalk, it is the morbidities, that develop as a result of Covid-19, that no one is taking about. The lasting, potentially life long disabilities that people will have are concerning. I believe that Leronlimab will prove to be an affective treatment for both the acute phase, as well as post acute phase of COVID-19.